The Biotechnology Innovation Organization (BIO) – the world’s largest science and public advocacy organization, representing 1,000 members — announced today that Rachel King, co-founder and former CEO of GlycoMimetics, Inc., has agreed to serve as interim President and CEO. King’s appointment follows Dr. Michelle McMurry-Heath stepping down as President and CEO to serve as an Advisor to the Executive Committee of the BIO Board of Directors. The organization is searching for a full-time successor.Continue reading
Author Archive: AZBio
Anuncia Medical, Inc., receives FDA clearance for the ReFlow® System Mini for the treatment of patients with hydrocephalus
SCOTTSDALE, Ariz., Sept. 29, 2022 /PRNewswire/ — Anuncia Medical, Inc., announced that the U.S. Food and Drug Administration (FDA) cleared the ReFlow® System Mini for the treatment of patients with hydrocephalus and other cerebrospinal fluid (CSF) disorders that require shunting.
Anuncia Medical, Inc. Honored with an AZBio Fast Lane Award
Relieving Pressure on the Brain
Cerebrospinal fluid (CSF) normally flows through the cavities (ventricles) of our brains and bathes our brain and spinal column. Hydrocephalus is a condition caused by a buildup of this fluid deep within the brain. The excess fluid puts pressure on the brain. This pressure can damage brain tissues and cause a range of brain function problems. Hydrocephalus can happen at any age, but it occurs more frequently among infants and adults 60 and over.Continue reading
AZBio Kicks of Arizona Bioscience Week on ABC15 (video)
Arizona Bioscience Week has begun. AZBio CEO, Joan Koerber-Walker, kicked things off on ABC15 Arizona and shared highlights of all the exciting things that are happening and how YOU can get connected with Arizona’s Health Innovators.
Check out all of the #AZBW2022 events at https://www.azbio.org/azbw2022 Continue reading
Phoenix Mayor Kate Gallego honored with AZBio Public Service Award
The path for a cure for cancer will run through Phoenix.
Sit down with Phoenix Mayor Kate Gallego and bring up the subject of biosciences, you will experience a burst of energy and insight about the innovation in healthcare taking place across Phoenix, including the growth of businesses creating jobs, and a personal passion that, “the path for a cure for cancer will run through Phoenix.”Continue reading
BMSEED Awarded Grant to develop a physiologically relevant pre-clinical drug screening platform for Alzheimer’s Disease and Traumatic Brain Injury
New Microfluidics Platform with embedded Stretchable Microelectrodes for Research on Alzheimer’s Disease and other Neurological and Neurodegenerative DiseasesContinue reading
Saving money for Medicare by abandoning new drugs for Medicare patients
By Steve Potts, PhD
The new Inflation Reduction Act was written in part to improve access to prescription drugs. But just like many potent drugs, the law too has side effects. As a small biotech drug developer, here’s the most toxic: It’s forcing me to choose to develop a drug for kids instead of a drug for their grandparents, when I could be developing both.Continue reading
Putting Patients First – Biomarker Testing in Arizona
In 2022, ACS CAN led a successful legislative campaign in Arizona to expand access to biomarker testing. Gov. Ducey, Rep. Regina Cobb, Dr. Rachna Shroff and Holly Hill reflect on the impact this law will have on patients across the state.